93 related articles for article (PubMed ID: 17290391)
1. Adrenomedullin is induced by hypoxia and enhances pancreatic cancer cell invasion.
Keleg S; Kayed H; Jiang X; Penzel R; Giese T; Büchler MW; Friess H; Kleeff J
Int J Cancer; 2007 Jul; 121(1):21-32. PubMed ID: 17290391
[TBL] [Abstract][Full Text] [Related]
2. Receptor activity-modifying proteins of adrenomedullin (RAMP2/3): Roles in the pathogenesis of ARDS.
Kasahara T; Tanaka M; Zhao Y; Kamiyoshi A; Sakurai T; Ichikawa-Shindo Y; Kawate H; Matsuda Y; Zhang Y; Guo Q; Li P; Hoshiyama K; Li J; Onishi N; Hayashi M; Sanjo H; Ishida K; Tanaka S; Kawamata M; Shindo T
Peptides; 2024 Jan; 171():171118. PubMed ID: 38012983
[TBL] [Abstract][Full Text] [Related]
3. Adrenomedullin has a cytoprotective role against endoplasmic reticulum stress for pancreatic β-cells in autocrine and paracrine manners.
Suetomi R; Ohta Y; Akiyama M; Matsumura T; Taguchi A; Yamamoto K; Kamatani T; Tanizawa Y
J Diabetes Investig; 2020 Jul; 11(4):823-833. PubMed ID: 31989791
[TBL] [Abstract][Full Text] [Related]
4. Anti-apoptotic effect of adrenomedullin gene delivery on Leydig cells by suppressing TGF-β1 via the Hippo signaling pathway.
Luo YW; Zhu XL; Li MY; Zhou JH; Yang ZM; Tong T; Chen BH; Qin SL; Liu BL; Hu W
Reprod Toxicol; 2023 Aug; 119():108418. PubMed ID: 37268150
[TBL] [Abstract][Full Text] [Related]
5. Adrenomedullin haploinsufficiency predisposes to secondary lymphedema.
Nikitenko LL; Shimosawa T; Henderson S; Mäkinen T; Shimosawa H; Qureshi U; Pedley RB; Rees MC; Fujita T; Boshoff C
J Invest Dermatol; 2013 Jul; 133(7):1768-76. PubMed ID: 23364478
[TBL] [Abstract][Full Text] [Related]
6. RAMP1 as a novel prognostic biomarker in pan-cancer and osteosarcoma.
Xie L; Xiao W; Fang H; Liu G
PLoS One; 2023; 18(10):e0292452. PubMed ID: 37796823
[TBL] [Abstract][Full Text] [Related]
7. Global lipid remodelling by hypoxia aggravates migratory potential in pancreatic cancer while maintaining plasma membrane homeostasis.
Agarwala PK; Nie S; Reid GE; Kapoor S
Biochim Biophys Acta Mol Cell Biol Lipids; 2023 Dec; 1868(12):159398. PubMed ID: 37748704
[TBL] [Abstract][Full Text] [Related]
8. Adrenomedullin is expressed in pancreatic cancer and stimulates cell proliferation and invasion in an autocrine manner via the adrenomedullin receptor, ADMR.
Ramachandran V; Arumugam T; Hwang RF; Greenson JK; Simeone DM; Logsdon CD
Cancer Res; 2007 Mar; 67(6):2666-75. PubMed ID: 17363587
[TBL] [Abstract][Full Text] [Related]
9. Expression of adrenomedullin in human colorectal tumors and its role in cell growth and invasion in vitro and in xenograft growth in vivo.
Nouguerède E; Berenguer C; Garcia S; Bennani B; Delfino C; Nanni I; Dahan L; Gasmi M; Seitz JF; Martin PM; Ouafik L
Cancer Med; 2013 Apr; 2(2):196-207. PubMed ID: 23634287
[TBL] [Abstract][Full Text] [Related]
10. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor.
McLatchie LM; Fraser NJ; Main MJ; Wise A; Brown J; Thompson N; Solari R; Lee MG; Foord SM
Nature; 1998 May; 393(6683):333-9. PubMed ID: 9620797
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia-induced apoptosis is blocked by adrenomedullin via upregulation of Bcl-2 in human osteosarcoma cells.
Wu XY; Hao CP; Ling M; Guo CH; Ma W
Oncol Rep; 2015 Aug; 34(2):787-94. PubMed ID: 26035796
[TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of interferon-γ signaling-based personalized heterogeneity and therapeutic strategies in patients with pancreatic cancer.
Chen X; Yuan Q; Guan H; Shi X; Sun J; Wu Z; Ren J; Xia S; Shang D
Front Oncol; 2023; 13():1227606. PubMed ID: 37941546
[TBL] [Abstract][Full Text] [Related]
13. Multi-biological functions of intermedin in diseases.
Yang Z; Li H; Wu P; Li Q; Yu C; Wang D; Li W
Front Physiol; 2023; 14():1233073. PubMed ID: 37745233
[TBL] [Abstract][Full Text] [Related]
14. Role of Pancreatic Tumour-Derived Exosomes and Their Cargo in Pancreatic Cancer-Related Diabetes.
Binang HB; Perera CJ; Apte MV
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373351
[TBL] [Abstract][Full Text] [Related]
15. Peptidergic Systems and Cancer: Focus on Tachykinin and Calcitonin/Calcitonin Gene-Related Peptide Families.
Sánchez ML; Rodríguez FD; Coveñas R
Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980580
[TBL] [Abstract][Full Text] [Related]
16. Chronic hypoxia is associated with transcriptomic reprogramming and increased genomic instability in cancer cells.
Abou Khouzam R; Sharda M; Rao SP; Kyerewah-Kersi SM; Zeinelabdin NA; Mahmood AS; Nawafleh H; Khan MS; Venkatesh GH; Chouaib S
Front Cell Dev Biol; 2023; 11():1095419. PubMed ID: 36968212
[TBL] [Abstract][Full Text] [Related]
17. Expression of the Calcitonin Receptor-like Receptor (CALCRL) in Normal and Neoplastic Tissues.
Wende B; Beyer AL; Ruhnke N; Kaemmerer D; Sänger J; Schulz S; Lupp A
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835377
[TBL] [Abstract][Full Text] [Related]
18. microRNAs Associated with Gemcitabine Resistance via EMT, TME, and Drug Metabolism in Pancreatic Cancer.
Funamizu N; Honjo M; Tamura K; Sakamoto K; Ogawa K; Takada Y
Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831572
[TBL] [Abstract][Full Text] [Related]
19. Islet amyloid polypeptide does not suppress pancreatic cancer.
Taylor AJ; Panzhinskiy E; Orban PC; Lynn FC; Schaeffer DF; Johnson JD; Kopp JL; Verchere CB
Mol Metab; 2023 Feb; 68():101667. PubMed ID: 36621763
[TBL] [Abstract][Full Text] [Related]
20. Circulating Levels of the Cardiovascular Biomarkers ST2 and Adrenomedullin Predict Outcome within a Randomized Phase III Lung Cancer Trial (RASTEN).
Gezelius E; Bendahl PO; Gallo W; de Oliveira KG; Ek L; Bergman B; Sundberg J; Melander O; Belting M
Cancers (Basel); 2022 Mar; 14(5):. PubMed ID: 35267617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
